Role of the Androgen Receptor in Human Breast Cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 1, 1998, Pages 95-103

  Birrell, S N ^a   Hall, R E ^a   Tilley, W D ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Androgen receptor; Androgens; Medroxyprogesterone acetate; Receptor variants

Indexed keywords

ANDROGEN RECEPTOR;

BREAST TUMOR; FEMALE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTORS, ANDROGEN;

EID: 0031597894     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018730519839     Document Type: Article

References (50)

1. S. M. Thorpe and C. Rose (1986). Oestrogen and progesterone receptor determinations in breast cancer; technology and biology. Cancer Surveys 5:505-525.
2. C. R. Wenger, S. Beardslee, M. A. Owens, G. Pounds, T. Oldaker, P. Vendely, M. R. Pandian, D. Harrington, G. M. Clark, and W. L. McGuire (1993). DNA Ploidy, S-Phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res. Treat. 28:9-26.
3. M. F. Pichon, P. Broet, H. Magdelenat, J. C. Delarue, F. Spyratos, J. P. Basuyan, S. Saez, A. Rallet, P. Courriere, R. Millon, and B. Asselain (1996). Prognostic value of steroid receptors after long term follw-up of 2257 operable breast cancers. Brit. J. Cancer 73:1545-1551.
4. O. A. Lea, S. Kvinnsland, and T. Thorsen (1989). Improved measurement of androgen receptors in human breast cancer. Cancer Res. 49:7162-7167.
5. N. Kimura, A. Mizokami, T. Oonuma, H. Sasano, and H. Nagura (1993). Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J. Histochem. Cytochem. 41:671-678.
6. J. A. Soreide, O. A. Lea, J. E. Varhaug, A. Skarstein, and S. Kvinnsland (1992). Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur. J. Surg. Oncol. 18:112-118.
7. V. Kuenenboumeester, T. H. Vanderkwast, W. L. Vanputten, C. Claassen, B. Vanooijen, and S. C. Henzenlogmans (1992). Immunohistochemical determination of androgen receptors in relation to estrogen and progesterone receptors in female breast cancer. Int. J. Cancer 52:581-584.
8. J. J. Isola (1993). Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J. Pathol. 170:31-35.
9. R. J. Santen, A. Manni, H. Harvey, and C. Redmond (1990). Endocrine treatment of breast cancer in women. Endocrine Rev. 11:221-265.
10. D. C. Tormey, M. E. Lippman, B. K. Edwards, and J. G. Cassidy (1983). Evaluation of Tamoxifen doses with and without fluoxymesterone in advanced breast cancer. Ann. Intern. Med. 98:139-144.
11. C. L. Clarke and R. L. Sutherland (1990). Progestin regulation of cellular proliferation. Endocrine Rev. 11:266-301.
12. F. A. Teulings, H. A. van Gilse, M. S. Henkelman, H. Portengen, and J. Alexieva-Figusch (1980). Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer. Cancer Res. 40:2557-2561.
13. S. Lundgren, P. E. Lonning, E. Utaaker, A. Aakvaag, and S. Kvinnsland (1990). Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer - I. General findings. J. Steroid Biochem. 36:99-104.
14. D. Chalbos, D. Haagensen, T. Parish, and H. Rochefort (1987). Identfication and androgen regulation of two proteins released by T-47D human breast cancer cells. Cancer Res. 47:2787-2792.
15. R. Poulin, D. Baker, D. Poirier, and F. Labrie (1989). Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat. 13:161-172.
16. R. Hackenberg, T. Havighorst, A. Filmer, A. H. Nia, and K. D. Schulz (1993). Medroxyprogesterone acetate inhibits the proliferation of estrogen-receptor and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor. Breast Cancer Res. Treat. 25:217-224.
17. R. Hackenberg, J. Hofmann, F. Holzel, and K. D. Schulz (1988). Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J. Cancer Res. Clin. Oncol. 114:593-601.
18. R. Poulin, D. Baker, and F. Labrie (1988). Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat. 12:213-225.
19. R. Hackenberg, S. Lüttchens, J. Hofmann, R. Kunzmann, F. Hölzel, and K. D. Schulz (1991). Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res. 51:5722-5727.
20. R. L. Sutherland, R. E. Hall, G. Y. Pang, E. A. Musgrove, and C. L. Clarke (1988). Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res. 48:5084-5091.
21. K. B. Horwitz, D. T. Zava, A. K. Thilagar, E. M. Jensen, and W. L. McGuire (1978). Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res. 38:2434-2437.
22. S. Dauvois, C. S. Geng, C. Levesque, Y. Merand, and F. Labrie (1991). Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res. 51:3131-3135.
23. S. N. Birrell, J. M. Bentel, T. E. Hickey, C. Ricciardelli, M. A. Weger, D. J. Horsfall, and W. D. Tilley (1995). Androgens Induce Divergent Proliferative Responses In Human Breast Cancer Cell Lines. J. Steroid Biochem. Mol. Biol. 52:459-467.
24. C. Chang, J. Kokontis, and S. Liao (1988). Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324-326.
25. D. B. Lubahn, D. R. Joseph, P. M. Sullivan, H. F. Willard, F. S. French, and E. M. Wilson (1988). Cloning of human androgen receptor complementary DNA and localization to the x chromosome. Science 240:327-330.
26. W. D. Tilley, M. Marcelli, J. D. Wilson, and M. J. McPhaul (1989). Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. USA 86:327-331.
27. R. E. Hall, W. D. Tilley, M. J. McPhaul, and R. L. Sutherland (1992). Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int. J. Cancer 52:778-784.
28. R. Hackenberg, T. Hawighorst, A. Filmer, E. P. Slater, K. Bock, and M. Beato (1992). Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells. J. Steroid Biochem. Mol. Biol. 43:599-607.
29. R. Poulin, J. Simard, C. Labrie, L. Petitclerc, M. Dumont, and L. Lagace (1989). Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology 125:392-399.
30. D. T. Zava and W. L. McGuire (1977). Estrogen receptors in androgen-induced breast tumor regression. Cancer Res. 37:1608-1610.
31. R. Hackenberg, J. Hofmann, G. Wolff, F. Holzel, and K. D. Schulz (1990). Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth. J. Cancer Res. Clin. Oncol. 116:492-498.
32. F. Labrie, R. Poulin, J. Simard, H. F. Zhao, C. Labrie, and S. Dauvois (1990). Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells. Ann. N. Y. Acad. Sci. 595:130-148.
33. R. Poulin, D. Baker, D. Poirier, and F. Labrie (1991). Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids. Breast Cancer Res. Treat. 17:197-210.
34. R. E. Hall, S. N. Birrell, W. D. Tilley, and R. L. Sutherland (1994). MDA-MB-453, An androgen-responsive human breast carcinoma cell line with a high level of androgen receptor expression. Eur. J. Cancer 30A:484-490.
35. S. N. Birrell, J. M. Bentel, D. J. Horsfall, and W. D. Tilley (1996). Androgen receptor expression and medroxyprogeste rone acetate therapy in human breast cancer. Proc. Amer. Assoc. Cancer Res. 37:237.
36. T. Ojasoo, J. P. Raynard, and J. C. Dore (1994). Affiliations among steroid receptors as revealed by multivariate analysis of steroid binding data. J. Steroid Biochem. Mol. Biol. 48:31-46.
37. S. N. Birrell, D. M. Roder, J. M. Bentel, D. J. Horfall, and W. D. Tilley (1995). Medroxyprogesterone acetate therapy in advanced breast cancer: The prognositic value of Androgen Receptor expression. J. Clin. Oncol. 13:1572-1577.
38. D. F. Hull, III, G. M. Clark, C. K. Osborne, G. C. Chamness, W. A. Knight, III, and W. L. McGuire (1983). Multiple estrogen receptor assays in human breast cancer. Cancer Res. 43:413-416.
39. G. E. Gross, G. M. Clark, G. C. Chamness, and W. L. McGuire (1984). Multiple progesterone receptor assays in human breast cancer. Cancer Res. 44:836-840.
40. C. A. Encarnacion, D. R. McGuire, W. L. Clark, S. A. W. Fuqua, and C. K. Osborne (1993). Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res. Treat. 26:237-246.
41. S. R. D. Johnston, G. Saccanijotti, I. E. Smith, J. Salter, J. Newby, and M. Coppen (1995). Changes in estrogen receptor, progesterone receptor, and ps2 expression in tamoxifen-resistant human breast cancer. Cancer Res. 55:3331-3338.
42. M. L. Graham, J. A. Smith, P. B. Jewett, and K. B. Horwitz (1992). Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry. Cancer Res. 52:593-602.
43. W. D. Tilley, S. S. Lim-Tio, D. J. Horsfall, J. O. Aspinall, V. R. Marshall, and J. M. Skinner (1994). Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining-measurement by color video image analysis. Cancer Res. 54:4096-4102.
44. C. M. Wilson and M. J. McPhaul (1994). A and B forms of the androgen receptor are present in human genital skin fibroplasts. Proc. Natl. Acad. Sci. USA 91:1234-1238.
45. C. A. Quigley, A. Debellis, K. B. Marschke, M. K. Elawady, E. M. Wilson, and F. S. French (1995). Androgen receptor defects - historical, clinical, and molecular perspectives. Endocrine Rev. 16:271-321.
46. J. D. Graham, C. Yeates, R. L. Balleine, S. S. Harvey, J. S. Milliken, A. M. Bilous, and C. L. Clarke (1995b). Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res. 55:5063-5068.
47. J. P. Elo, L. Kvist, K. Leinonen, V. Isomaa, P. Henttu, and O. Lukkarinen (1996). Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J. Clin. Endocrinol. Metabol. 80:3494-3500.
48. X. Zhu, A. A. Daffada, C. M. Chan, and M. Dowsett (1997). Identification of an exon 3 deletion-splice variant androgen receptor mRNA in human breast cancer. Int. J. Cancer (in press).
49. L. V. Nazereth and N. L. Weigel (1996). Activation of the human androgen receptor through a protein kinase a signaling pathway. J. Biol. Chem. 271:19900-19907.
50. Z. Culig, A. Hobisch, M. V. Cronauer, C. Radmayr, J. Trapman, A. Hittmair, G. Bartsch, and H. Klocker (1994). Androgen receptor activation in prostate tumor cell lines by insulin-like growth factor-I, Keratinocyte Growth Factor, and epidermal growth factor. Cancer Res. 54:5474-5478.